Profound Medical (PROF) EBITDA Margin (2019 - 2026)
Profound Medical's quarterly EBITDA Margin came in at 150.98% in Q1 2026, up 25424.0% year-on-year from N/an in Q1 2025, and down 14.23% quarter-over-quarter from 132.17% in Q4 2025.
Profound Medical has reported EBITDA Margin for 8 years, with the latest figure at 150.98% in Q1 2026.
- For the quarter ending Q1 2026, EBITDA Margin rose 25424.0% year-over-year to 150.98%; the trailing twelve-month figure through Mar 2026 stood at 200.52% (up 9798.0% YoY), and the FY2025 full-year result was 250.26%, up 3662.0% from the prior year.
- EBITDA Margin for Q1 2026 stood at 150.98%, down from 132.17% in the prior quarter.
- The five-year high for EBITDA Margin was 1620.76% in Q4 2022, with the low at 6838.5% in Q4 2023.
- Average EBITDA Margin over 5 years is 329.49%, with a median of 150.98% recorded in 2026.
- Year-over-year, EBITDA Margin soared 671635 bps in 2022 and sank 845927 bps in 2023.
- Tracing PROF's EBITDA Margin over 5 years: stood at 1620.76% in 2022, then slumped by 522 bps to 6838.5% in 2023, then jumped by 98 bps to 165.59% in 2024, then rose by 20 bps to 132.17% in 2025, then decreased by 14 bps to 150.98% in 2026.
- The last three EBITDA Margin figures came in at 150.98% (Q1 2026), 132.17% (Q4 2025), and 166.1% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 16.24% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 28.97% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 14.52% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 21.42% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 10.04% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 19.94% |
| 10 | Profound Medical | 244.28 Mn | 193.99 Mn | 3.83 Mn | -150.98% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -150.98% |
| Dec 31, 2025 | -132.17% |
| Sep 30, 2025 | -166.10% |
| Jun 30, 2025 | -587.16% |
| Mar 31, 2025 | -405.23% |
| Dec 31, 2024 | -165.59% |
| Sep 30, 2024 | -345.44% |
| Jun 30, 2024 | -378.34% |
| Mar 31, 2024 | -524.95% |
| Dec 31, 2023 | -6,838.50% |
| Sep 30, 2023 | 379.63% |
| Jun 30, 2023 | 401.75% |
| Mar 31, 2023 | 367.63% |
| Dec 31, 2022 | 1,620.76% |
| Sep 30, 2022 | 404.62% |
| Jun 30, 2022 | 384.10% |
| Mar 31, 2022 | 534.60% |
| Dec 31, 2021 | -5,095.59% |
| Sep 30, 2021 | 299.84% |
| Jun 30, 2021 | 243.01% |
| Mar 31, 2021 | 924.33% |
| Dec 31, 2020 | 654.97% |
| Sep 30, 2020 | 0.00% |
| Jun 30, 2020 | 383.73% |
| Mar 31, 2020 | 421.30% |
| Dec 31, 2019 | -936.86% |
| Sep 30, 2019 | 889.04% |
| Jun 30, 2019 | 974.99% |
| Mar 31, 2019 | 184.31% |